Principal Financial Group Inc Castle Biosciences Inc Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q4 2024

A detailed history of Principal Financial Group Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 1,435,665 shares of CSTL stock, worth $40.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,435,665
Holding current value
$40.5 Million
% of portfolio
0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
BUY
$26.52 - $34.67 $38.1 Million - $49.8 Million
1,435,665 New
1,435,665 $38.3 Million
Q3 2024

Oct 31, 2024
BUY
$17.4 - $31.47 $702,559 - $1.27 Million
40,377 Added 2.7%
1,538,520 $43.9 Million
Q2 2024

Jul 29, 2024
SELL
$18.84 - $24.94 $646,758 - $856,165
-34,329 Reduced 2.24%
1,498,143 $32.6 Million
Q1 2024

Apr 29, 2024
SELL
$18.06 - $25.3 $960,810 - $1.35 Million
-53,201 Reduced 3.36%
1,532,472 $33.9 Million
Q4 2023

Feb 07, 2024
BUY
$12.19 - $22.43 $1.26 Million - $2.32 Million
103,503 Added 6.98%
1,585,673 $34.2 Million
Q3 2023

Nov 02, 2023
BUY
$13.28 - $20.3 $1.62 Million - $2.48 Million
122,169 Added 8.98%
1,482,170 $25 Million
Q2 2023

Aug 07, 2023
BUY
$11.66 - $26.0 $849,477 - $1.89 Million
72,854 Added 5.66%
1,360,001 $18.7 Million
Q1 2023

May 09, 2023
BUY
$19.47 - $28.49 $7.33 Million - $10.7 Million
376,327 Added 41.32%
1,287,147 $29.2 Million
Q4 2022

Feb 09, 2023
BUY
$18.08 - $30.0 $8.59 Million - $14.3 Million
475,080 Added 109.03%
910,820 $21.4 Million
Q3 2022

Nov 09, 2022
BUY
$22.51 - $34.32 $4.19 Million - $6.39 Million
186,064 Added 74.52%
435,740 $11.4 Million
Q2 2022

Aug 10, 2022
BUY
$16.0 - $45.99 $1.16 Million - $3.32 Million
72,226 Added 40.7%
249,676 $5.48 Million
Q1 2022

May 09, 2022
SELL
$33.17 - $46.98 $173,047 - $245,094
-5,217 Reduced 2.86%
177,450 $7.96 Million
Q4 2021

Feb 09, 2022
BUY
$39.06 - $67.58 $501,960 - $868,470
12,851 Added 7.57%
182,667 $7.83 Million
Q3 2021

Nov 09, 2021
BUY
$60.13 - $77.6 $59,468 - $76,746
989 Added 0.59%
169,816 $11.3 Million
Q2 2021

Aug 10, 2021
BUY
$50.07 - $76.78 $4.02 Million - $6.16 Million
80,263 Added 90.63%
168,827 $12.4 Million
Q1 2021

May 10, 2021
BUY
$58.92 - $97.33 $601,691 - $993,933
10,212 Added 13.03%
88,564 $6.06 Million
Q4 2020

Feb 08, 2021
BUY
$43.6 - $73.05 $2.18 Million - $3.66 Million
50,052 Added 176.86%
78,352 $5.26 Million
Q3 2020

Nov 06, 2020
BUY
$38.47 - $52.03 $69,246 - $93,654
1,800 Added 6.79%
28,300 $1.46 Million
Q2 2020

Aug 05, 2020
BUY
$27.28 - $43.01 $722,920 - $1.14 Million
26,500 New
26,500 $999,000

Others Institutions Holding CSTL

# of Institutions
199
Shares Held
25.9M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $742M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email